Fig. 2From: A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma – a case reportAnalysis of the MEN1 gene revealed a new mutation in exon 5 (variant c.812_820del, p.Gly271_Leu273del). The prediction of the new variant pathogenicity was performed with Mutation Taster (http://www.mutationtaster.org) and PROVEAN (http://provean.jcvi.org/index.php) software and revealed deleterious mutationBack to article page